(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ASCENDIS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ASCENDIS

ST13

US500000079063323

Class

5, 42, 45

Filing

79063323

Registration

3731597

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

54

Latest update

03/13/2026

Trademark type

Word

Nice classes

5, 42, 45

Filing date

11/26/2008

Registration date

12/29/2009

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/09/2020

Last transaction

03/13/2026

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

DK

Examiner

HELLMAN, ELI J

Law office

M30

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Ascendis Pharma A/S
Ascendis Pharma A/S
Ascendis Pharma A/S

Representatives

Paul F. Kilmer Holland & Knight, LLP

Technical classification

Nice Classes

Class 5Class 42Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and veterinary preparations for the treatment of physical and mental illnesspharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system; for the treatment of inflammatory disorders; for use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; sanitary preparations for medical purposesdietetic foods adapted for medical usedisinfectants for sanitary purposes; fungicidesherbicides

Class 42

Scientific research within the medicalpharmaceutical and bacteriological area; providing scientific consultancy and information in relation to the aforementioned scientific research; testing of pharmaceuticals; packaging designdesigning and development of medical equipment; developing pharmaceutical and medical preparations; design and development of pharmaceutical formulations; design and development of granulation technology and tablet technology; providing scientific consultancy and information relating to the design and development of granulation technology and tablet technology

Class 45

Licensing of industrial propertylegal services

Publications

History of USPTO decisions and trademark events.

54 publications found

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

03/12/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/10/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/24/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/27/2021

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

01/08/2021

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

09/30/2020

INPC

INVALIDATION PROCESSED

09/30/2020

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

09/09/2020

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

01/09/2020

71AG

REGISTERED-SEC.71 ACCEPTED

01/09/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/08/2020

ES71

TEAS SECTION 71 RECEIVED

12/04/2019

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

12/29/2018

RNWL

INTERNATIONAL REGISTRATION RENEWED

12/13/2018

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

01/18/2018

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

11/17/2017

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

10/03/2017

INPC

INVALIDATION PROCESSED

10/03/2017

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

10/02/2017

CCCN

COUNTERCLAIM CANC. NO. 999999

07/14/2017

CCON

COUNTERCLAIM OPP. NO. 999999

06/07/2017

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

02/02/2017

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

02/02/2017

E15R

TEAS SECTION 15 RECEIVED

12/05/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/02/2016

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

11/29/2016

PR71

POST REGISTRATION ACTION MAILED - SEC.71

08/10/2016

PR71

POST REGISTRATION ACTION MAILED - SEC.71

08/08/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/08/2016

ES71

TEAS SECTION 71 RECEIVED

06/29/2016

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/06/2013

FICS

FINAL DISPOSITION NOTICE SENT TO IB

04/26/2010

FIMP

FINAL DISPOSITION PROCESSED

04/26/2010

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/29/2010

R.PR

REGISTERED-PRINCIPAL REGISTER

12/29/2009

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/13/2009

PUBO

PUBLISHED FOR OPPOSITION

10/13/2009

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

09/09/2009

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/08/2009

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/08/2009

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/08/2009

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/08/2009

ALIE

ASSIGNED TO LIE

09/08/2009

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/03/2009

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/03/2009

RFNT

REFUSAL PROCESSED BY IB

03/27/2009

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/06/2009

RFRR

REFUSAL PROCESSED BY MPU

03/06/2009

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/06/2009

CNRT

NON-FINAL ACTION WRITTEN

03/05/2009

DOCK

ASSIGNED TO EXAMINER

02/26/2009

MAFR

APPLICATION FILING RECEIPT MAILED

01/13/2009

NWAP

NEW APPLICATION ENTERED

01/09/2009

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/08/2009

Continuous trademark protection

Get notified about every new filing that threatens ASCENDIS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.